GlassScriptPhysician profile
Ashley Lawrence
NPI 1215205828
$5,163.79
in general payments reported to CMS, 2019-2025
23 companies · $878 in 2025
The $878 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,046 · 2022: $1,033 · 2023: $1,170 · 2024: $1,036 · 2025: $878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,796 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,796.40 |
| Education | $288.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,069.05 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Abbvie INC. | $878.63 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $684.42 | 2021-2025 | |
| Pfizer INC. | $510.42 | 2021-2025 | |
| Genzyme Corporation | $371.38 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $354.29 | 2021-2025 | Ilumya |
| Galderma Laboratories, L.P. | $261.65 | 2024-2025 | Nemluvio |
| Incyte Corporation | $248.72 | 2021-2024 | Opzelura |
| Lilly USA, LLC | $189.39 | 2021-2025 | Ebglyss, Taltz |
| E.R. Squibb & Sons, L.L.C. | $182.59 | 2022-2025 | Sotyktu |
| Leo Pharma INC. | $104.69 | 2022-2025 | Adbry |
| Regeneron Healthcare Solutions, INC. | $42.39 | 2025 | Dupixent |
| Ucb, INC. | $39.25 | 2021-2024 | Bimzelx |
| Dermavant Sciences, INC. | $36.80 | 2023-2024 | Vtama |
| Journey Medical Corporation | $33.55 | 2022-2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $31.88 | 2023 | Exparel, Iovera, Zilretta |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $24.68 | 2024 | |
| Botanix Sb INC | $22.29 | 2025 | Sofdra |
| Biofrontera INC. | $20.02 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.46 | 2022 | |
| Organon LLC | $16.76 | 2025 | Vtama |
| Fresenius Kabi USA, LLC | $13.47 | 2023 | Idacio |
| Mayne Pharma Commercial LLC | $10.01 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.